Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention

被引：73
|
作者：
Stephenson, Kathryn E. [1 ,2 ]
Wagh, Kshitij [3 ,4 ]
Korber, Bette [3 ,4 ]
Barouch, Dan H. [1 ,2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA
[2] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Boston, MA 02114 USA
[3] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA
[4] New Mexico Consortium, Los Alamos, NM 87545 USA
来源：
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 | 2020年 / 38卷
基金：
美国国家卫生研究院;
关键词：
vaccine; broadly neutralizing antibody; HIV-1; viral diversity; prevention; bNAb; HUMAN-IMMUNODEFICIENCY-VIRUS; DEMAND PREEXPOSURE PROPHYLAXIS; CELLULAR IMMUNE-RESPONSES; MUCOSAL SHIV CHALLENGE; T-LYMPHOCYTE RESPONSES; HIGHLY PATHOGENIC SIV; ENVELOPE TRIMER; DOUBLE-BLIND; ANTIRETROVIRAL PROPHYLAXIS; ANTI-HIV-1; ANTIBODIES;
D O I：
10.1146/annurev-immunol-080219-023629
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Development of improved approaches for HIV-1 prevention will likely be required for a durable end to the global AIDS pandemic. Recent advances in preclinical studies and early phase clinical trials offer renewed promise for immunologic strategies for blocking acquisition of HIV-1 infection. Clinical trials are currently underway to evaluate the efficacy of two vaccine candidates and a broadly neutralizing antibody (bNAb) to prevent HIV-1 infection in humans. However, the vast diversity of HIV-1 is a major challenge for both active and passive immunization. Here we review current immunologic strategies forHIV-1 prevention, with a focus on current and next-generation vaccines and bNAbs.
引用
收藏
页码：673 / 703
页数：31
相关论文
共 50 条
  • [41] Towards HIV-1 remission: potential roles for broadly neutralizing antibodies
    Halper-Stromberg, Ariel
    Nussenzweigz, Michel C.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 415 - 423
  • [42] Broadly neutralizing antibodies and vaccine design against HIV-1 infection
    Qian Wang
    Linqi Zhang
    [J]. Frontiers of Medicine, 2020, 14 : 30 - 42
  • [43] HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
    Dufloo, Jeremy
    Bruel, Timothee
    Schwartz, Olivier
    [J]. RETROVIROLOGY, 2018, 15
  • [44] HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies
    Sliepen, Kwinten
    Sanders, Rogier W.
    [J]. EXPERT REVIEW OF VACCINES, 2016, 15 (03) : 349 - 365
  • [45] Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
    Elise Landais
    Penny L. Moore
    [J]. Retrovirology, 15
  • [46] Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
    Peter D. Kwong
    John R. Mascola
    Gary J. Nabel
    [J]. Nature Reviews Immunology, 2013, 13 : 693 - 701
  • [47] Engineering broadly neutralizing antibodies for HIV prevention and therapy
    Hua, Casey K.
    Ackerman, Margaret E.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2016, 103 : 157 - 173
  • [48] Broadly neutralizing antibodies for the treatment and prevention of HIV infection
    Caskey, Marina
    [J]. CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) : 49 - 55
  • [49] Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
    Chikaev, A. N.
    Rudometov, A. P.
    Merkulyeva, Yu A.
    Karpenko, L., I
    [J]. VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2021, 25 (05): : 562 - 572
  • [50] Lessons from babies: inducing HIV-1 broadly neutralizing antibodies
    Tomaras, Georgia D.
    Haynes, Barton F.
    [J]. NATURE MEDICINE, 2014, 20 (06) : 583 - 585
12345